3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
15
Recurrence
8
Hodgkin Disease
6
Breast Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Sezary Syndrome
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Renal Cell
2
Interventions
mogamulizumab
3
Cyclophosphamide
3
Lenalidomide
2
Alemtuzumab
2
ruxolitinib
1
peginterferon alfa-2b
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
denileukin diftitox
1
belinostat
1
Zidovudine
1
Vincristine
1
Raltegravir Potassium
1
Prednisone
1
Oxaliplatin
1
Introns
1
Interleukin-15
1
Gemcitabine
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Daclizumab
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Bortezomib
1
B3(Fv)-PE38KDEL recombinant immunotoxin
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia-Lymphoma, Adult T-Cell
×
Panobinostat
×
Clear all
No trials found.